LongeCity Media & Archives / Podcast

2022 Interview with Dr Matthew O'Connor

Thu Nov 03, 2022 4:49 pm

Listen to this episode

Download the recording

Dr O'Connor provides updates on progress at Cyclarity
Founder of Underdog Pharmaceutical, now renamed Cyclarity Therapeutics, Dr Matthew O'Connor talks about new cyclodextrin-based drugs in development.

2022-11-03_longecity_now_matthew_oconnor_2022.mp3

Files and availability

Read-only archive. Access follows the preserved publication rules; unavailable historical files are marked where applicable.